Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01901588 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 63
- Enrollment target
NCT01901588 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 63 participants.
The verdict
NCT01901588, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 63 participants
- Enrollment target
Study Summary
This study is trying to see if using precedex pre-operatively prevents emergence delirium in pediatric (ages 1-7) patients undergoing strabismus surgery.
Interventions
- OTHER Placebo
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01901588
The ClinicalTrials.gov registry entry for NCT01901588 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01901588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01901588 about?
NCT01901588 is a clinical study titled "Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery". This study is trying to see if using precedex pre-operatively prevents emergence delirium in pediatric (ages 1-7) patients undergoing strabismus surgery.
What is the current status of trial NCT01901588?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 63 participants. The study started on 2012-03. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01901588?
The interventions under investigation include: Placebo (OTHER), Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT01901588?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.